SHL Medical acquires 100% of the shares in Swiss company LCA Automation

SHL Medical acquires LCA Automation

SHL Medical announces the acquisition of LCA Automation AG, a Swiss innovative automation solutions provider. The acquisition is SHL Medical’s response to the growing market demand for drug delivery solutions and will support its manufacturing operations globally, especially the upcoming Swiss manufacturing site in Zug.  

SHL Medical announces the acquisition of LCA Automation AG, a Swiss innovative automation solutions provider. The acquisition is SHL Medical’s response to the growing market demand for drug delivery solutions and will support its manufacturing operations globally, especially the upcoming Swiss manufacturing site in Zug.  

SHL Medical, a world-leading provider of advanced drug delivery solutions headquartered in Zug, announced the acquisition of Swiss-based LCA Automation, a leading provider of innovative automation solutions, as well as its subsidiaries in Mexico and China, effective June 29, 2023. 

The acquisition of LCA Automation is part of SHL Medical’s ongoing strategy to respond to the exponentially growing market demand, expand its global presence, and further strengthen SHL Medical’s vertical capabilities globally. SHL Medical and LCA Automation have a strong track record of excellence in automation. The combination of their expertise and long-standing experience in different industries allows SHL Medical to increase its automation capacity in Europe further and leverage synergies to offer customers more efficient solutions along the value chain that include faster timelines and shorter supply chains.  

Extension of strengths for customers
Acquiring LCA Automation will support SHL Medical’s manufacturing operations globally, especially in providing automation expertise as well as tool maintenance and metal manufacturing for the Swiss manufacturing site that is currently under construction. This local extension of strengths in the automation field further increases high-speed and large-scale manufacturing. With the acquisition of LCA Automation, SHL is also reasserting one of its distinctive features in terms of complete in-house manufacturing. By operating as a comprehensive service provider, customers benefit from more flexibility along the whole production value chain. 

“We are excited to welcome LCA Automation to the SHL family”, says Ulrich Faessler, CEO of SHL Medical. “LCA Automation’s expertise in automation and manufacturing solutions will complement our existing capabilities and enable us to offer a more comprehensive range of services to our customers and accelerate innovation.” 

Chris Rennhard, CEO of LCA Automation, adds: “SHL Medical and LCA Automation joining forces in production process technology and equipment manufacturing is a great benefit to the customers. The resulting high-level factory automation technology will enable the shortest timelines to fulfill market demands, while maintaining in-house process control and quality monitoring.”